Xtag CF60 Kit V2

FDA 510(k) K083845 · Luminex Molecular Diagnostics, Inc.

Substantially Equivalent

510(k) numberK083845

Submission

Device name
Xtag CF60 Kit V2
Applicant
Luminex Molecular Diagnostics, Inc.
Toronto, Ontario, CA
Received
December 24, 2008
Decision date
December 11, 2009
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
NUA – System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5900
Specialty
Immunology

The cftr gene mutation detection system is a device used to simultaneously detect and identify a panel of mutations and variants in the cftr gene. It is intended as an aid in confirmatory diagnostic testing of individuals with suspected cystic fibrosis (cf), carrier identification, and newborn screening. This device is not intended for stand-alone diagnostic purposes, prenatal diagnostic…

Other 510(k)s with product code NUA

510(k)DeviceApplicantDecision
K163347xTAG Cystic Fibrosis 39 Kit v2NUA · Special Luminex Molecular Diagnostics, Inc.12/15/2016SESK
K163336xTAG Cystic Fibrosis 60 Kit v2, xTAG Data Analysis Software (TDAS) CFTRNUA · Special Luminex Molecular Diagnostics, Inc.12/15/2016SESK
K083846Xtag Cystic Fibrosis 39 Kit V2, (CFTR 39 Kit V2), Model I027C0231, I027D0266, I027E0267NUA · Traditional Luminex Molecular Diagnostics, Inc.09/01/2009SE
K083294Verigene CFTR Nucleic Acid Test and Verigene CFTR Polyt Nucleic Acid TestNUA · Traditional Nanosphere, Inc.07/24/2009SE
K090901Esensor CF Genotyping Testm Esensor System, Esensor Cystic Fibrosis Genotyping Test…NUA · Traditional Osmetech Molecular Diagnostics07/06/2009SE
K063787Inplex CF Molecular TestNUA · Traditional Third Wave Technologies, Inc.03/13/2008SE
K062028Cystic Fibrosis Genotyping Assay, Model 6L20-01NUA · Traditional Celera Diagnostics09/07/2007SE
K060627Tag-It Cystic Fibrosis KitNUA · Special Tm Bioscience Corporation06/07/2006SE
K060543Esensor Cystic Fibrosis Carrier Detection System, Model Esensor 4800NUA · Special Clinical Micro Sensors, Inc.03/28/2006SE
K051435Esensor Cystic Fibrosis Carrier Detection Test , Esensor 4800 DNA Detection System…NUA · Traditional Clinical Micro Sensors01/19/2006SE

More from Clinical Micro Sensors

510(k)DeviceDecision
K242613NxTAG® Respiratory Pathogen PanelOCC · Special 10/02/2024SE
K231758NxTAG Respiratory Pathogen Panel v2 (NxTAG RPP v2)QOF · Traditional 03/11/2024SE
K193167NxTAG Respiratory Pathogen Panel, NxTAG Respiratory Pathogen Panel Files, SYNCT SoftwareOCC · Special 12/11/2019SE
K191161xTAG Gastrointestinal Pathogen Panel (GPP)PCH · Special 11/12/2019SE
K191160xTAG Gastrointestinal Pathogen Panel (GPP), xTAG Data Analysis Software (TDAS GPP)PCH · Special 11/04/2019SE
K183030xTAG Gastrointestinal Pathogen Panel (GPP), xTAG Data Analysis Software (TDAS GPP)PCH · Special 11/30/2018SE
K183023xTAG Gastrointestinal Pathogen Panel (GPP), xTAG Data Analysis Software (TDAS GPP)PCH · Special 11/30/2018SE
K170492xTAG CYP2D6 Kit v3NTI · Special 08/11/2017SE
K163347xTAG Cystic Fibrosis 39 Kit v2NUA · Special 12/15/2016SESK
K163336xTAG Cystic Fibrosis 60 Kit v2, xTAG Data Analysis Software (TDAS) CFTRNUA · Special 12/15/2016SESK

Questions and answers

When was Xtag CF60 Kit V2 cleared by the FDA?

Xtag CF60 Kit V2 (K083845) received a 510(k) decision of Substantially Equivalent on December 11, 2009, 352 days after the submission was received.

What is the product code of K083845?

The FDA product code is NUA – System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection, a Class II (moderate risk) device regulated under 21 CFR 866.5900.